NEW YORK (GenomeWeb) – The US Food and Drug Administration has listed SpeeDx's ResistancePlus MG Positive Control kit for sale in the US, the company said today.

The kit will be sold through SpeeDx's recently incorporated US entity. The Australian parent firm has also been registered with the FDA as a medical device manufacturing establishment. Clinical trials in the US for ResistancePlus MG remain on track, it said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.

Dec
12
Sponsored by
Illumina

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.